LEADER 02938nam  22006014a 450 
001 9910143414003321
005 20170815115921.0
010   $a1-280-65456-2
010   $a9786610654567
010   $a0-470-09798-1
010   $a0-470-09797-3
035   $a(CKB)1000000000355029
035   $a(EBL)275890
035   $a(OCoLC)476021452
035   $a(SSID)ssj0000239180
035   $a(PQKBManifestationID)11205801
035   $a(PQKBTitleCode)TC0000239180
035   $a(PQKBWorkID)10235171
035   $a(PQKB)11109755
035   $a(MiAaPQ)EBC275890
035   $a(PPN)243368100
035   $a(EXLCZ)991000000000355029
100   $a20060609d2007      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aRole of lipid excipients in modifying oral and parenteral drug delivery$b[electronic resource] $ebasic principles and biological examples /$fedited by Kishor M. Wasan
210   $aHoboken, N.J. $cWiley-Interscience$dc2007
215   $a1 online resource (217 p.)
300   $aDescription based upon print version of record.
311   $a0-471-73952-9 
320   $aIncludes bibliographical references and index.
327   $aROLE OF LIPID EXCIPIENTS IN MODIFYING ORAL AND PARENTERAL DRUG DELIVERY; CONTENTS; PREFACE; CONTRIBUTORS; CHAPTER 1 INTERACTION OF DRUG TRANSPORTERS WITH EXCIPIENTS; CHAPTER 2 FORMULATION ISSUES AROUND LIPID-BASED ORAL AND PARENTERAL DELIVERY SYSTEMS; CHAPTER 3 LIPID-BASED PARENTERAL DRUG DELIVERY SYSTEMS: BIOLOGICAL IMPLICATIONS; CHAPTER 4 PRINCIPLES IN THE DEVELOPMENT OF INTRAVENOUS LIPID EMULSIONS; CHAPTER 5 PROTEIN ADSORPTION PATTERNS ON PARENTERAL LIPID FORMULATIONS: KEY FACTOR DETERMINING THE IN VIVO FATE; CHAPTER 6 NANOPARTICLE TARGETING FOR DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
327   $aCHAPTER 7 LIPID-COATED PERFLUOROCARBON STRUCTURES AS PARENTERAL THERAPEUTIC AGENTSINDEX
330   $aThis comprehensive resource covers the fundamentals, formulation, and biopharmaceutical issues of lipid-based drug delivery. It presents the principles of lipid absorption and covers formulation issues, such as dissolution testing and stability testing, and physiological and biopharmaceutical issues, including the role of specific enzymes, the evaluation of transport systems in the body, and the mechanisms governing the transport of water-insoluble drugs.
606   $aLipids$xTherapeutic use
606   $aExcipients
606   $aDrugs$xDosage forms
615  0$aLipids$xTherapeutic use.
615  0$aExcipients.
615  0$aDrugs$xDosage forms.
676   $a615.6
676   $a615/.7
701   $aWasan$b Kishor M$0932407
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910143414003321
996   $aRole of lipid excipients in modifying oral and parenteral drug delivery$92098130
997   $aUNINA